featured
Federal Report Shows Youth Marijuana Use ‘Remained Stable’ Even As More States Legalized In Recent Years

Published
13 hours agoon

New federal health data indicate that while past-year marijuana use in the U.S. overall has climbed in recent years, the rise has been “driven by increases…among adults 26 years or older.” As for younger Americans, rates of both past-year use and cannabis use disorder, by contrast, “remained stable among adolescents and young adults between 2021 and 2024.”
In fact, past-year use among people ages 12 to 20 fell to a four-year low in 2024, the data show—even as a growing number of states enact laws legalizing marijuana for people over the age of 21. The results are contrary to arguments voiced by prohibitionist advocates who have long argued that it is important to keep cannabis illegal for adults in order to prevent youth use.
The data published by the Substance Abuse and Mental Health Services Administration (SAMHSA) come from the agency’s release of results from the latest National Survey on Drug Use and Health (NSDUH), which annually since 1971 has asked Americans ages 12 and older questions about their drug use, mental health and related treatment.
“The annual NSDUH provides timely statistical information on substance use and mental health in the U.S.,” SAMHSA Principal Deputy Assistant Secretary Art Kleinschmidt said in an agency press release Monday. “These data are incredibly valuable to researchers, clinicians, policymakers, and others, allowing for greater understanding of the nation’s behavioral health, and to help inform actions in support of President Trump’s vision to Make America Healthy Again.”
Among all respondents, the poll found, self-reported marijuana use within the past 12 months rose from 19.0 percent in 2021 to 22.3 percent last year.
While the SAMHSA press release sent on Monday about the report doesn’t highlight different trends by age levels, companion data from the survey distinguish the overall rise in marijuana use from stable or declining trends among “underage” Americans, aged 12 to 20.
In 2024, the reported rate of past-year cannabis use among that age group was 16.7 percent, hitting a four-year low.
The rate rose between 2021 (17.9 percent) and 2022 (19.2 percent), then fell during the next to years to 18.4 percent in 2023 and 16.7 percent last year.

2024 National Survey on Drug Use and Mental Health, SAMHSA
Between 2021 and 2024, the states of Connecticut, Delaware, Maryland, Minnesota, Missouri, New Mexico, New York, Ohio, Rhode Island and Virginia all legalized cannabis for adults over 21 year of age.
A supporting graphic in from SAMHSA also breaks down use by age group somewhat.
It shows that young adults, ages 18 to 25, remain most likely to have used marijuana in the past year, at 35 percent—though that rate was lower than at any other point since 2021.
About 1 in 10 young people ages 18 to 25 (10.4 percent) reported past-year use, meanwhile—also lower than at any other time over the four-year period.

2024 National Survey on Drug Use and Mental Health, SAMHSA
SAMHSA cautioned that given increases in adult use of marijuana, the generally stable trends among youth use shouldn’t be taken for granted.
“The increases in past-year illicit drug use and past-year drug use disorders are largely driven by increases in marijuana use and marijuana use disorder among adults 26 years or older,” the federal report says. “Although marijuana use and use disorder trends remained stable among adolescents and young adults between 2021 and 2024, the increase in adult use is important to inform prevention and treatment activities given changing attitudes around marijuana use and the shifting state policy landscape which has increased risk for marijuana use and use disorder among young people, and enabled the ready availability of high-potency marijuana products linked to negative health impacts in communities across the country.”
Other notable substance-related findings from the new survey include that past-year use of hallucinogens increased among all Americans 12 and older, from 2.7 percent in 2021 to 3.6 percent last year.
Past-year cocaine use declined slightly over the same time period, from 1.7 percent to 1.5 percent. Prescription opioid misuse also diminished from 3.0 percent to 2.6 percent.
People with any sort of drug use disorder during the past year, meanwhile, increased from 8.7 precent to 9.8 percent. Those figures do not include alcohol use disorder, which decreased from 10.6 percent to 9.7 percent.
Overall, 16.8 percent of Americans—48.4 million people—reported some sort of substance use disorder in 2024, the NSDUH data show.
Questions related to recovery, meanwhile, found that “1.7 million adults aged 18 or older (or 12.2%) perceived that they ever had a problem with their use of alcohol or drugs,” SAMHSA said. “Among these adults, 74.3% (or 23.5 million people) considered themselves to be in recovery or to have recovered.”

2024 National Survey on Drug Use and Mental Health, SAMHSA
Other questions looked at modes of marijuana use, finding that combustion remains the most popular form of consumption, with 73.9 percent of cannabis users reporting smoking within the past year. About half (49.8 percent) ate or drank cannabis products, while 39.8 reported vaping, 14.1 reported dabbing and 14.1 reported “some other mode of marijuana use.”
Respondents were able to choose as many responses to that question as applied.
As for vaping specifically, the data show it’s especially common among younger marijuana users, with 71.1 percent of respondents 12 to 17 saying they vaped cannabis in the past year. Among those 18 to 25, 52.0 percent said they had vaped, meanwhile, as did 33.0 percent of those 26 or older.

2024 National Survey on Drug Use and Mental Health, SAMHSA
Overall, 38.0 percent of cannabis consumers 12 and older said they vaped marijuana in 2024, while 62.0 percent said they used cannabis but did not vape.
SAMHSA’s report on the NSDUH findings a year ago also included a longer-term look at marijuana use trends, finding that youth use appeared to have fallen significantly in the preceding decade, as dozens of states legalized marijuana for adult or medical use.
The percentage of young people aged 12 to 17 who had ever tried marijuana, for example, dropped by 18 percent from 2014—when the first legal recreational cannabis sales in the U.S. launched—to 2023. Past-year and past-month use rates among young people also declined during that time period.
While the NSDUH survey has been conducted for decades, its methodology has changed over the years, making some historical comparisons difficult or impossible. Data from recent years, including 2023, 2022 and 2021 “should not be combined with data from 2020 or prior years for a variety of methodological reasons,” a SAMHSA spokesperson said last year in an email about that report.
A year earlier, in 2022, NSDUH for the first time asked respondents about their methods of marijuana consumption—including “smoking; vaping; dabbing waxes, shatter, or concentrates; eating or drinking; putting drops, strips, lozenges, or sprays in their mouth or under their tongue; applying lotion, cream, or patches to their skin; taking pills; or some other way.”
Release of the latest NSDUH data comes on the heels of a SAMHSA webinar earlier this month in which a Johns Hopkins University researcher acknowledged that self-reported cannabis consumption by adults has risen as more states have legalized, while use by youth has generally remained flat or fallen.
“Use among youth is one of the biggest areas of concern related to the legalization and increased accessibility of cannabis,” the presenter said, “but surprisingly, that cohort has actually maintained relatively stable [for] both past-year and daily use.”
A separate secret shopper study out of New York City earlier this year found that state-licensed marijuana retailers were far more consistent about discouraging youth access to cannabis compared to illicit stores, with regulated outlets consistently verifying the age of would-be buyers as well as avoiding cartoon signage and products that appeal to young people.
All of the licensed retailers that were observed checked purchasers’ ID both before store entry and prior to purchase, that study found. Unregulated stores, by contrast, checked IDs before entry only 10 percent of the time, and verified ages before purchase less than half (48 percent) of the time.
Across the U.S., research suggests that marijuana use by young people has generally fallen in states that legalize the drug for adults.
A report from the advocacy group Marijuana Policy Project (MPP), for example, found that youth marijuana use declined in 19 out of 21 states that legalized adult-use marijuana—with teen cannabis consumption down an average of 35 percent in the earliest states to legalize.
The report cited data from a series of national and state-level youth surveys, including the annual Monitoring the Future (MTF) Survey, which is supported by the National Institute on Drug Abuse (NIDA).
The latest version of the MTF, released late last year, found that cannabis use among eighth, 10th and 12 graders is now lower than before the first states started enacting adult-use legalization laws in 2012. There was also a significant drop in perceptions by youth that cannabis is easy to access in 2024 despite the widening adult-use marketplace.
Another survey from the U.S. Centers for Disease Control and Prevention (CDC) last year also showed a decline in the proportion of high-school students reporting past-month marijuana use over the past decade, as dozens of states moved to legalize cannabis.
At the state level, MPP’s assessment looked at research such as the Washington State Healthy Youth Survey that was released in April 2024.
That survey showed declines in both lifetime and past-30-day marijuana use in recent years, with striking drops that held steady through 2023. The results also indicated that perceived ease of access to cannabis among underage students has generally fallen since the state enacted legalization for adults in 2012—contrary to fears repeatedly expressed by opponents of the policy change.
In June of last year, meanwhile, the biannual Healthy Kids Colorado Survey found that rates of youth marijuana use in the state declined slightly in 2023—remaining significantly lower than before the state became one of the first in the U.S. to legalize cannabis for adults in 2012.
The findings broadly track with other past surveys that have investigated the relationship between jurisdictions that have legalized marijuana and youth cannabis use.
For example, a Canadian government report recently found that daily or near-daily use rates by both adults and youth have held steady over the last six years after the country enacted legalization.
Another U.S. study reported a “significant decrease” in youth marijuana use from 2011 to 2021—a period in which more than a dozen states legalized marijuana for adults—detailing lower rates of both lifetime and past-month use by high-school students nationwide.
Another federal report published last summer concluded that cannabis consumption among minors—defined as people 12 to 20 years of age—fell slightly between 2022 and 2023.
Separately, a research letter published by the Journal of the American Medical Association (JAMA) in April 2024 said there’s no evidence that states’ adoption of laws to legalize and regulate marijuana for adults have led to an increase in youth use of cannabis.
Another JAMA-published study earlier that month that similarly found that neither legalization nor the opening of retail stores led to increases in youth cannabis use.
In 2023, meanwhile, a U.S. health official said that teen marijuana use has not increased “even as state legalization has proliferated across the country.”
Another earlier analysis from the U.S. Centers for Disease Control and Prevention found that rates of current and lifetime cannabis use among high school students have continued to drop amid the legalization movement.
A separate NIDA-funded study published in the American Journal of Preventive Medicine in 2022 also found that state-level cannabis legalization was not associated with increased youth use. The study demonstrated that “youth who spent more of their adolescence under legalization were no more or less likely to have used cannabis at age 15 years than adolescents who spent little or no time under legalization.”
Yet another 2022 study from Michigan State University researchers, published in the journal PLOS One, found that “cannabis retail sales might be followed by the increased occurrence of cannabis onsets for older adults” in legal states, “but not for underage persons who cannot buy cannabis products in a retail outlet.”
The trends were observed despite adult use of marijuana and certain psychedelics reaching “historic highs” in 2022, according to separate 2023 data.

Author: mscannabiz.com
MScannaBIZ for all you Mississippi Cannabis News and Information.
You may like
-
New York State Office of Cannabis Management miscalculated distances between schools, dispensaries
-
Texans Deserve Choice, Not a Monopoly: Texas Hemp Business Council Urges Lawmakers to Defeat SB 5
-
Massachusetts Psychiatric Society Endorses Bill To Decriminalize Psilocybin Possession
-
Georgia lawmakers reevaluate medical cannabis, hemp regulations
-
GOP Senator Rides To The Rescue Of Hemp
-
Goldflower Cannabis Opening 9th Florida Dispensary in Bonita Springs
featured
Texans Deserve Choice, Not a Monopoly: Texas Hemp Business Council Urges Lawmakers to Defeat SB 5

Published
27 minutes agoon
July 29, 2025
[PRESS RELEASE] – AUSTIN, Texas, July 28, 2025 – The Texas Hemp Business Council (THBC) issued the following statement:
“As S.B. 5 heads to the Senate floor during the special session of the 89th Texas Legislature, Lieutenant Governor Dan Patrick and Senators Charles Perry and Roland Gutierrez are actively looking to gift-wrap the entire cannabis market to a few select state-licensed [medical] marijuana companies, one of which already controls over 75% of the market.
“Their claim that the restrictive Texas Compassionate Use Program (TCUP) can replace hemp-derived cannabinoids is misleading and dangerous.
“TCUP currently serves just over 100,000 patients and requires registration, physician prescriptions, higher prices and fewer options. While H.B. 46 was an attempt to improve the program, it does little to expand real access to a restrictive and expensive TCUP program that serves an entirely different purpose than hemp.
“Meanwhile, hemp is legal and regulated under federal and state law and serves millions of adult consumers and veterans who rely on affordable, accessible alternatives for wellness, pain relief and more.
“S.B. 5 would destroy a $10 billion industry that supports over 53,000 jobs and eliminate economic opportunity for thousands of small business owners across the state. All being done under the false flag of ‘safety,’ while the real goal is market control by a politically connected few. This isn’t about protecting public health; it’s about protecting a monopoly.
“Governor Abbott’s veto message was clear: Regulate hemp responsibly; don’t ban it. Texans deserve choice, not coercion. S.B. 5 is prohibition disguised as policy, and lawmakers should reject it. Public opinion, economic data and common sense all point in the same direction: This is a manufactured crisis driven by special interests, not public demand.
“At a time when Texas faces real and pressing challenges like strengthening flood warning systems, redistricting and providing meaningful property tax relief, some Senate leaders are spending this special session pushing a hemp ban Texans clearly don’t want. It’s a clear example of misplaced priorities and misguided policies.
“That’s why THBC and the vast majority of Texans strongly support a common-sense alternative that includes 21-plus age limits, child-resistant packaging and setbacks from schools. It’s the right path forward for public safety, economic freedom and the future of hemp in Texas.”

Author: mscannabiz.com
MScannaBIZ for all you Mississippi Cannabis News and Information.
featured
Massachusetts Psychiatric Society Endorses Bill To Decriminalize Psilocybin Possession

Published
1 hour agoon
July 29, 2025
“We are encouraged by the growing body of rigorous research exploring the use of psychedelics, including psilocybin in treating treatment-resistant types of mental illness.”
By Jack Gorsline, HorizonMass
Massachusetts psychedelic policy advocates recently marked a significant milestone at a July 15 legislative hearing, which featured testimony on four of the 12 psychedelics-related bills filed this year on Beacon Hill. The hearing was highlighted by a historic, first-ever endorsement of psychedelic decriminalization-specific legislation anywhere by a professional psychiatric society: The Massachusetts Psychiatric Society (MPS).
Among the bills addressed at the hearing of the Joint Committee on the Judiciary was H.1726, sponsored by state Rep. Homar Gómez (D), which seeks to decriminalize the possession of psilocybin.
Another proposal, H.1624 from state Rep. Mike Connolly (D), proposes a psychedelics task force to consider equity in psychedelic access.
H.1858, from state Rep. Marc Lombardo (R), aims to reduce legal penalties for psilocybin possession by imposing a $100 fine for quantities under one gram, effectively decriminalizing small amounts.
And S.1113, sponsored by state Sen. Cindy Friedman (D), directs the Department of Public Health (DPH) to create a trial program for medically supervised psilocybin therapy, specifically excluding ownership by “cannabis industry organizations, psychedelic molecule development companies or pharmaceutical companies.”
Massachusetts Psychiatric Society supports psychedelics measures
The endorsement from the Massachusetts Psychiatric Society, a professional organization representing approximately 1,400 psychiatrists across the state, was a notable development.
Dr. Jhilam Biswas, speaking on behalf of the MPS, stated, “I’m here today to express the society’s support for H.1624, H.1726, H.1858 and S.1113, bills that allow for the dismissal of complaints for the simple possession of psilocybin, provided that if the individual meets clear safety-based criteria, which is being over the age of 21, not operating a vehicle and not endangering of children.”
Dr. Biswas clarified that the society’s support was not a “blanket endorsement of recreational psychedelic use,” noting its opposition to last November’s Ballot Question 4, which members believed was “too far reaching and lacked necessary safeguards.” She emphasized, “While we know there is promising research happening in psychedelic medicines in the field of psychiatry and medicine, broad and premature access to many different substances without caution is not only dangerous, but does impact the research community.”
In contrast, Dr. Biswas described the current bills as a “more balanced and responsible approach,” applying “narrowly to define situations to adults over 21 who are not driving and not endangering children, and whose action caused no harm to others.” She added, “It gives courts more discretion and it maintains important public safety protections while avoiding any unnecessary criminal penalties.”
The MPS also acknowledged the amount of research into psychedelics for mental illness treatment.
“Moreover, we are encouraged by the growing body of rigorous research exploring the use of psychedelics, including psilocybin in treating treatment-resistant types of mental illness,” Dr. Biswas said. “Institutions like our local EMC hospitals and research centers in Massachusetts are leading these studies with promising early outcomes.” She concluded by urging legislators to view these bills “not just at, this as criminal justice reform, but as a public health opportunity.”
According to the organization Mass Healing, the MPS’s endorsement of these three psilocybin decriminalization proposals marks the first time any branch of the American Psychiatric Association (APA) has endorsed psychedelics legislation of any kind.
Curiously, the MPS’s recent endorsement contrasts with testimony provided at a previous psychedelics bill hearing last month. Outgoing MPS President Dr. Nassir Ghaemi opposed H.2506, which sought to decriminalize possession of up to 50 grams of dried psilocybin mushrooms, stating he was speaking “on his own behalf, as well as that of the society.”
Plant medicine advocates testify on Beacon Hill
Former Yes on 4 campaign staffer Graham Moore also spoke in favor of the bills, acknowledging that the previous measure “went too far for the people of Massachusetts right now.” The advocate championed the current proposals as “much more narrowly tailored,” and emphasized that “people don’t want lives ruined over simple possession, but people also do not want unlimited green light to everybody’s all sorts of psychedelics.”
Moore also refuted claims of increased public health problems in areas that have decriminalized psilocybin, citing Cambridge, Massachusetts, and Colorado as well as the Netherlands, where legal psilocybin availability has not led to widespread abuse due to its non-addictive nature.
Timothy Morris is a Billerica resident who, along with fellow advocate and Mass resident Henry Morgan, submitted H.1726 to state Rep. Gómez. At the hearing, he expressed his gratitude for the process: “I’m thankful that we’re able to get the ball rolling so soon after question 4, as well as for Dr. Biswas’s supporting testimony.”
Morris added, “The fact that Institutions—such as the Massachusetts Psychiatric Society—are beginning to support the decriminalization movement, marks the start of a powerful paradigm shift for related public policy.”
This article is syndicated by the MassWire news service of the Boston Institute for Nonprofit Journalism. If you want to see more reporting like this, make a contribution at givetobinj.org.

Author: mscannabiz.com
MScannaBIZ for all you Mississippi Cannabis News and Information.

Politics makes strange bedfellows and add in cannabis and you got some interesting news
In a dramatic turn this week, a GOP Senator rides to the rescue of hemp. While as a party they haven’t lined up support cannabis and hemp, GOP Senator Rand Paul (R‑KY) successfully blocked a proposed federal ban on hemp-derived THC products had been inserted into a critical spending bill on agriculture and related funding. The provision sought to redefine hemp by capping total THC—including delta‑8, delta‑10, and THCA—rather than just delta‑9 THC, effectively outlawing most edible hemp products
RELATED: Guess Who Is A Big Supporter Of Legalizing Marijuana
Paul argued the language would “destroy hemp farmers in my state” and devastate an emerging national industry, threatening thousands of jobs and billions in revenue. Kentucky, once a leading tobacco-growing state, has become a national leader in hemp production—generating tens of millions annually in cultivation, processing, and manufacturing jobs. His intervention represents a major victory for hemp advocates.

The hemp-derived THC market in the U.S.—centered on delta‑8, delta‑10, and similar compounds—jumped nearly 1,283% from 2020 to 2023, rising from $200.5 million to approximately $2.8 billion. Meanwhile, the broader U.S. legal cannabis (marijuana) industry reached roughly $38.5 billion in 2024, expected to climb to over $44 billion in 2025.
Globally, the industrial hemp market—including fiber, seeds, food and wellness applications—is estimated at $6.6 billion in 2024, and projected to hit $25–26 billion by 2034. North America is a hub for both cannabis and hemp, with legal cannabis valued at $26.6 billion in 2024 and forecast to grow over 10‑fold to $285 billion by 2034.
Industry stakeholders emphasize hemp’s unique position: it’s federally legal under the 2018 Farm Bill, so long as delta‑9 THC remains under 0.3%. Federal safety net distinguishes hemp‑THC products from marijuana, which remains federally illicit despite many states permitting recreational or medical use. Hemp has become increasingly popular, in Texas, Bayou City Hemp Company, the parent of Bayou Beverage, has taken hemp‑derived THC drinks mainstream.
RELATED: Gen Z Increasing Alcohol Intake Without Cutting Cannabis
Senator Paul’s move reflects the intersection of politics, agriculture, and emerging consumer markets. As lawmakers weigh the future of hemp‑THC regulation, the broader cannabis industry—and its relationship with alcohol and public policy—continues its rapid evolution.

Author: mscannabiz.com
MScannaBIZ for all you Mississippi Cannabis News and Information.

New York State Office of Cannabis Management miscalculated distances between schools, dispensaries

Texans Deserve Choice, Not a Monopoly: Texas Hemp Business Council Urges Lawmakers to Defeat SB 5

Massachusetts Psychiatric Society Endorses Bill To Decriminalize Psilocybin Possession

Georgia lawmakers reevaluate medical cannabis, hemp regulations

GOP Senator Rides To The Rescue Of Hemp

Goldflower Cannabis Opening 9th Florida Dispensary in Bonita Springs

Inside Morocco’s Cannabis Culture and Legal Industry Shift: From Kif to Clinics

Ky. Governor urges President Trump to oppose blocking cannabis rescheduling

Gap in cannabis education leaves medical providers in the dark

FDA Commissioner Links Use Of Cannabis Products To Heart Problems And Psychosis

New York Cannabis Regulators Messed Up Dispensary Location Guidance; 152 Stores Impacted

Richard Lee, Who Made Cannabis Legalization Inevitable, Has Died. His Mission Lives On

GOP Senator Successfully Blocks Federal Hemp THC Ban In Key Spending Bill

RollPros Launches Blackbird XXL: The First-Ever Automated Blunt Rolling Machine

Ozzy Osbourne, Parkinson’s and the Promise of Magic Mushrooms: Could They Have Helped?

Pennsylvania: Reading City Council Adopts Municipal Decriminalization Ordinance

VIDEO: Guest Smokes Weed on Mario Kart After Attraction Breaks Down At Universal Studios Hollywood

Federal Report Shows Youth Marijuana Use ‘Remained Stable’ Even As More States Legalized In Recent Years

Cannabis ballot initiative brings lawsuit to Menominee

Proposed DOJ Rule Says Marijuana Users Likely Wouldn’t Be Eligible To Have Gun Rights Restored

Kentucky medical marijuana cultivator brings in half-grown plants to speed harvest

Federal Researchers Claim First-Ever Detection Of Cannabinoids In Human Breath After Use Of Marijuana Edibles

BREEDING FOR BIG BUDS (1986)

New DEA Admin Sidelines Cannabis Rescheduling Despite Earlier Promises

Alert: Department of Cannabis Control updates data dashboards with full data for 2023

Connecticut Appoints The US’s First Cannabis Ombudsperson – Yes there is a pun in there and I’m Sure Erin Kirk Is Going To Hear It More Than Once!

5 best CBD creams of 2024 by Leafly

EU initiative begins bid to open access to psychedelic therapies

Free delta-9 gummies from Bay Smokes

New Study Analyzes the Effects of THCV, CBD on Weight Loss

5 best autoflower seed banks of 2024 by Leafly

May 2024 Leafly HighLight: Pink Runtz strain

Curaleaf Start Process Of Getting Their Claws Into The UK’s National Health System – With Former MP (Resigned Today 30/5/24) As The Front Man

Mississippi city official pleads guilty to selling fake CBD products

Discover New York’s dankest cannabis brands [September 2024]

Local medical cannabis dispensary reacts to MSDH pulling Rapid Analytics License – WLBT

Horn Lake denies cannabis dispensary request to allow sale of drug paraphernalia and Sunday sales | News

Press Release: CANNRA Calls for Farm Bill to Clarify Existing State Authority to Regulate Hemp Products

Nevada CCB to Accept Applications for Cannabis Establishments in White Pine County – “Only one cultivation and one production license will be awarded in White Pine County”

5 best THC drinks of 2024 by Leafly

The Daily Hit: October 2, 2024

6 best CBD gummies of 2024 by Leafly

5 best delta-9 THC gummies of 2024 by Leafly

Weekly Update: Monday, May 13, 2024 including, New Guide for Renewals & May Board meeting application deadline

People In This State Googled ‘Medical Marijuana’ The Most, Study Shows

PRESS RELEASE : Justice Department Submits Proposed Regulation to Reschedule Marijuana

Thailand: Pro-cannabis advocates rally ahead of the government’s plan to recriminalize the plant

Press Release: May 9, STIIIZY and Healing Urban Barrios hosted an Expungement Clinic & Second Chance Resource Fair
Trending
-
California Cannabis Updates1 year ago
Alert: Department of Cannabis Control updates data dashboards with full data for 2023
-
Breaking News1 year ago
Connecticut Appoints The US’s First Cannabis Ombudsperson – Yes there is a pun in there and I’m Sure Erin Kirk Is Going To Hear It More Than Once!
-
best list12 months ago
5 best CBD creams of 2024 by Leafly
-
Business10 months ago
EU initiative begins bid to open access to psychedelic therapies
-
Bay Smokes1 year ago
Free delta-9 gummies from Bay Smokes
-
cbd1 year ago
New Study Analyzes the Effects of THCV, CBD on Weight Loss
-
autoflower seeds10 months ago
5 best autoflower seed banks of 2024 by Leafly
-
California1 year ago
May 2024 Leafly HighLight: Pink Runtz strain